Testing effectiveness (Phase 2)UnknownNCT05911048
What this trial is testing
A Clinical Trial of Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) in Booster Vaccination
Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 3,100